Trial Profile
A clinical trial to investigate dalazatide in patients with lupus
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Dalazatide (Primary)
- Indications Lupus nephritis
- Focus Adverse reactions
- 20 Jun 2016 New trial record